» Articles » PMID: 21851480

Clonal Dissemination of Klebsiella Pneumoniae ST258 Harbouring KPC-2 in Argentina

Overview
Publisher Elsevier
Date 2011 Aug 20
PMID 21851480
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

The present work describes the abrupt emergence of Klebsiella pneumoniae carbapenemase (KPC) and characterizes the first 79 KPC-producing enterobacteria from Argentina (isolated from 2006 to 2010). The emergence of bla(KPC-2) was characterized by two patterns of dispersion: the first was the sporadic occurrence in diverse enterobacteria from distant geographical regions, harbouring plasmids of different incompatibility groups and bla(KPC-2) in an unusual genetic environment flanked by ISKpn8-Δbla(TEM-1) and ISKpn6-like. bla(KPC-2) was associated with IncL/M transferable plasmids; the second was the abrupt clonal spread of K. pneumoniae ST258 harbouring bla(KPC-2) in Tn4401a.

Citing Articles

Emergence of NDM-producing Enterobacterales infections in companion animals from Argentina.

de Mendieta J, Arguello A, Menocal M, Rapoport M, Albornoz E, Mas J BMC Vet Res. 2024; 20(1):174.

PMID: 38702700 PMC: 11067382. DOI: 10.1186/s12917-024-04020-z.


KPC-2 allelic variants in isolates resistant to ceftazidime-avibactam from Argentina: , , and .

Sanz M, Pasteran F, de Mendieta J, Brunetti F, Albornoz E, Rapoport M Microbiol Spectr. 2024; 12(3):e0411123.

PMID: 38319084 PMC: 10913460. DOI: 10.1128/spectrum.04111-23.


Plasmid genomic epidemiology of carbapenemase-producing in Canada, 2010-2021.

Lerminiaux N, Mitchell R, Bartoszko J, Davis I, Ellis C, Fakharuddin K Antimicrob Agents Chemother. 2023; 67(12):e0086023.

PMID: 37971242 PMC: 10720558. DOI: 10.1128/aac.00860-23.


Antimicrobial resistance, pathogenic potential, and genomic features of carbapenem-resistant isolated in Chile: high-risk ST25 clones and novel mobile elements.

Veloso M, Arros P, Acosta J, Rojas R, Berrios-Pasten C, Varas M Microbiol Spectr. 2023; :e0039923.

PMID: 37707451 PMC: 10581085. DOI: 10.1128/spectrum.00399-23.


Oral Administration of CRL1505 Modulates Lung Innate Immune Response against ST25.

Dentice Maidana S, Imamura Y, Elean M, Albarracin L, Nishiyama K, Suda Y Microorganisms. 2023; 11(5).

PMID: 37317122 PMC: 10222716. DOI: 10.3390/microorganisms11051148.